Table 4.
The bivariable and multivariable logistic regression analyses for factors associated with virological failure among first-line HAART at MTUTH in 2020.
| Variables | Categories | Cases | Controls | COR (95% CI) | AOR (95% CI) | p-value |
|---|---|---|---|---|---|---|
| Sex | Male | 76 | 54 | 1.85 (1.16, 2.95) | 1.89 (1.04, 3.47) | 0.038* |
| Female | 70 | 92 | 1 | 1 | ||
| History of substance use | Yes | 77 | 40 | 2.96 (1.79, 4.75) | 2.67 (1.40, 4.95) | 0.003* |
| No | 69 | 106 | 1 | 1 | ||
| Chronic illnessa | Yes | 40 | 12 | 4.21 (2.12, 8.51) | 1.80 (0.61, 5.27) | 0.28 |
| No | 106 | 134 | 1 | 1 | ||
| Baseline Hgb | <12 | 95 | 52 | 3.36 (1.80, 5.35) | 3.22 (1.82, 5.99) | 0.001* |
| ≥12 | 51 | 94 | 1 | 1 | ||
| WHO staging at ART initiation | Stage 1 | 49 | 75 | 1 | 1 | |
| Stage 2 | 55 | 41 | 2.05 (1.19, 3.53) | 1.25 (0.63, 2.50) | 0.52 | |
| Stage 3 | 35 | 28 | 1.91 (1.03,3.53) | 0.48 (1.91, 1.20) | 0.11 | |
| Stage 4 | 7 | 2 | 5.35 (1.07, 26.85) | 0.44 (0.49, 4.08) | 0.47 | |
| Opportunistic Infections through follow up | Yes | 42 | 8 | 6.96 (3.07, 15.38) | 4.73 (1.76, 12.11) | 0.001* |
| No | 104 | 138 | 1 | 1 | ||
| HIV status disclosure | Disclosed | 65 | 58 | 1 | 1 | |
| Not disclosed | 81 | 88 | 1.22 (0.67–2.35) | 0.98 (0.46–1.89) | 0.33 | |
| Restart after interruption | Yes | 27 | 7 | 4.50 (1.89, 10.71) | 2.45 (1.69, 7.35) | 0.001* |
| No | 119 | 139 | 1 | 1 | ||
| ART drug adherence | Poor | 29 | 8 | 4.27 (1.87, 6.87) | 3.84 (1.77, 5.95) | 0.002 |
| Good | 117 | 138 | 1 | |||
| Baseline opportunistic infections | Yes | 41 | 13 | 3.99 (1.74–5.33) | 2.05 (0.91–4.78) | 0.007 |
| No | 105 | 133 | 1 |
Hypertension, heart failure, diabetes mellitus (DM), and chronic kidney disease (CKD).
Bacterial pneumonia, tuberculosis (TB), Herpes zoster, and oral candidiasis, and the
symbol indicate the variables significant in multivariable analysis at p-value < 0.05.
Bold values indicates statistically significant variables in the multivariable regression analysis.